ANROVSVTGN• 3 Months (Normalized)
ANRO vs VTGN (Alto Neuroscience Inc. vs Vistagen Therapeutics Inc.)
Showing Closing Date Range from Jul 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+10.26%
Alto Neuroscience Inc.
Normalized Baseline0.00%
VTGN Performance $0.37
+54.17%
Vistagen Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin VTGN LEADS
-43.91 pts
VTGN outperforming by 43.91 percentage points
ANROVTGN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO VTGN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(59 dates)
| Date | ANRO Price | ANRO Gain (%) | VTGN Price | VTGN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $27.50 | +10.26% | $0.37 | +54.17% | -43.91% |
| Sep 22, 2026 | $30.78 | +23.42% | $0.25 | +4.17% | +19.25% |
| Sep 21, 2026 | $30.63 | +22.81% | $0.23 | -4.17% | +26.98% |
| Sep 18, 2026 | $30.27 | +21.37% | $0.24 | +0.00% | +21.37% |
| Sep 17, 2026 | $30.98 | +24.22% | $0.23 | -4.17% | +28.39% |
| Sep 16, 2026 | $30.00 | +20.29% | $0.23 | -4.17% | +24.46% |
| Sep 15, 2026 | $30.25 | +21.29% | $0.24 | +0.00% | +21.29% |
| Sep 14, 2026 | $31.68 | +27.02% | $0.24 | +1.33% | +25.69% |
| Sep 11, 2026 | $32.00 | +28.31% | $0.24 | +0.00% | +28.31% |
| Sep 10, 2026 | $31.68 | +27.02% | $0.24 | +0.00% | +27.02% |
| Sep 09, 2026 | $34.07 | +36.61% | $0.24 | +0.00% | +36.61% |
| Sep 08, 2026 | $35.81 | +43.58% | $0.24 | +0.00% | +43.58% |
| Sep 04, 2026 | $35.55 | +42.54% | $0.24 | +0.00% | +42.54% |
| Sep 03, 2026 | $36.40 | +45.95% | $0.25 | +4.17% | +41.78% |
| Sep 02, 2026 | $36.64 | +46.91% | $0.25 | +4.17% | +42.74% |
Page 1 of 4